Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A F Sima

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Current Drug Targets|January 29, 2008
Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?Anders A F Sima, Hideki Kamiya
The Review of Diabetic Studies : RDS|December 30, 2009
The relevance of C-Peptide in diabetes and its complications: an introduction to the special issueAnders A F Sima, John Wahren
Annals of the New York Academy of Sciences|December 8, 2006
Diabetic neuropathy differs in type 1 and type 2 diabetesAnders A F Sima, Hideki Kamiya
Experimental Diabesity Research|June 17, 2004
The C-peptide signalingGeorge Grunberger, Anders A F Sima
The Review of Diabetic Studies : RDS|December 30, 2009
C-Peptide is Relevant in Type 1 Diabetes and its Complications: Summary and Conclusions to the Special IssueJohn Wahren, Anders A F Sima
The Review of Diabetic Studies : RDS|May 10, 2007
Diabetes and Alzheimer's disease - is there a connection?Anders A F Sima, Zhen-Guo Li
Diabetes|April 28, 2005
The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic ratsAnders A F Sima, Zhen-guo Li
Experimental Diabesity Research|June 17, 2004
C-peptide and central nervous system complications in diabetesZhen-Guo Li, Anders A F Sima
Experimental Diabesity Research|June 17, 2004
Type 1 diabetic neuropathy and C-peptideAnders A F Sima, Weixian Zhang, George Grunberger
Experimental Diabetes Research|October 17, 2009
Dynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetesHideki Kamiya, Weixian Zhang, Anders A F Sima
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Current Drug Targets|January 29, 2008
Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?Anders A F Sima, Hideki Kamiya
The Review of Diabetic Studies : RDS|December 30, 2009
The relevance of C-Peptide in diabetes and its complications: an introduction to the special issueAnders A F Sima, John Wahren
Annals of the New York Academy of Sciences|December 8, 2006
Diabetic neuropathy differs in type 1 and type 2 diabetesAnders A F Sima, Hideki Kamiya
Experimental Diabesity Research|June 17, 2004
The C-peptide signalingGeorge Grunberger, Anders A F Sima
The Review of Diabetic Studies : RDS|December 30, 2009
C-Peptide is Relevant in Type 1 Diabetes and its Complications: Summary and Conclusions to the Special IssueJohn Wahren, Anders A F Sima
The Review of Diabetic Studies : RDS|May 10, 2007
Diabetes and Alzheimer's disease - is there a connection?Anders A F Sima, Zhen-Guo Li
Diabetes|April 28, 2005
The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic ratsAnders A F Sima, Zhen-guo Li
Experimental Diabesity Research|June 17, 2004
C-peptide and central nervous system complications in diabetesZhen-Guo Li, Anders A F Sima
Experimental Diabesity Research|June 17, 2004
Type 1 diabetic neuropathy and C-peptideAnders A F Sima, Weixian Zhang, George Grunberger
Experimental Diabetes Research|October 17, 2009
Dynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetesHideki Kamiya, Weixian Zhang, Anders A F Sima
Pageof 7